SluzevichJCHallMRRoyV. Subcutaneous panniculitis-like T-cell lymphoma after rituximab. J Am Acad Dermatol2012; 67: e223–e225.
2.
SchmutzJLTrechotP. Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide. Ann Dermatol Venereol2013; 140: 246–247.
3.
PapenfussJSAounPBiermanPJ. Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations. Clin Lymphoma2002; 3: 175–180.
4.
ParveenZThompsonK. Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med2009; 133: 303–308.
5.
KongYDaiBKongJC. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol2008; 32: 1495–1502.
WilkinsKTurnerRDolevJC. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol2006; 54: 189–206.
8.
AdamsAEZwickerJCurielC. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol2004; 51: 660–662.
9.
ChenGGoeddelDV. TNF-R1 signalling: a beautiful pathway. Science2002; 296: 1634–1635.
10.
Gonzalez-StawinskiGVYuPBLoveSD. Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab). Clin Immunol2001; 98: 175–179.
11.
DasanuCA. Intrinsic and treatment-related immune alterations in chronic lymphocytic leukemia and their impact for clinical practice. Expert Opin Pharmacother2008; 9: 1481–1494.
12.
MudieNYSwerdlowAJHigginsCD. Risk of second malignancy after non-Hodgkin’s lymphoma: a British cohort study. J Clin Oncol2006; 24: 1568–1574.
GrangeFAvrilMFEsteveE. Coexistent cutaneous T-cell lymphoma and B-cell malignancy. French study group on cutaneous lymphomas. J Am Acad Dermatol1994; 31: 724–731.
15.
VasmatzisGJohnsonSHKnudsonRA. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood2012; 120: 2280–2289.
